Onconetix, Inc. (ONCO)
0.6123
-0.02
(-3.12%)
USD |
NASDAQ |
Aug 28, 16:00
0.6113
0.00 (0.00%)
After-Hours: 20:00
Onconetix 30-Day Average Daily Volume : 279040.3 for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 279040.3 |
| August 27, 2026 | 278618.8 |
| August 26, 2026 | 281403.8 |
| August 25, 2026 | 290167.4 |
| August 24, 2026 | 294943.6 |
| August 21, 2026 | 308756.6 |
| August 20, 2026 | 444395.7 |
| August 19, 2026 | 441003.7 |
| August 18, 2026 | 442977.9 |
| August 17, 2026 | 451952.7 |
| August 14, 2026 | 525602.8 |
| August 13, 2026 | 530961.2 |
| August 12, 2026 | 543179.1 |
| August 11, 2026 | 570265.1 |
| August 10, 2026 | 568956.8 |
| August 07, 2026 | 571948.8 |
| August 06, 2026 | 573046.6 |
| August 05, 2026 | 616121.9 |
| August 04, 2026 | 618397.2 |
| August 03, 2026 | 617887.1 |
| July 31, 2026 | 629801.9 |
| July 30, 2026 | 712073.3 |
| July 29, 2026 | 827850.5 |
| July 28, 2026 | 802626.3 |
| July 27, 2026 | 810876.8 |
| Date | Value |
|---|---|
| July 24, 2026 | 824072.0 |
| July 23, 2026 | 831579.2 |
| July 22, 2026 | 834994.5 |
| July 21, 2026 | 840097.3 |
| July 20, 2026 | 845424.4 |
| July 17, 2026 | 817978.5 |
| July 16, 2026 | 826679.2 |
| July 15, 2026 | 830330.3 |
| July 14, 2026 | 833322.8 |
| July 13, 2026 | 847724.3 |
| July 10, 2026 | 842798.5 |
| July 09, 2026 | 724184.1 |
| July 08, 2026 | 752331.2 |
| July 07, 2026 | 826428.5 |
| July 06, 2026 | 837350.7 |
| July 02, 2026 | 861286.7 |
| July 01, 2026 | 1.296M |
| June 30, 2026 | 1.376M |
| June 29, 2026 | 1.343M |
| June 26, 2026 | 1.341M |
| June 25, 2026 | 1.339M |
| June 24, 2026 | 1.336M |
| June 23, 2026 | 1.282M |
| June 22, 2026 | 1.270M |
| June 18, 2026 | 1.269M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Aprea Therapeutics, Inc. | 346267.0 |
| ACADIA Pharmaceuticals, Inc. | 1.636M |
| Alnylam Pharmaceuticals, Inc. | 2.050M |
| Anika Therapeutics, Inc. | 117828.7 |
| Savara, Inc. | 1.710M |